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Summary
 
The observation that revelation of immunocryptic epitopes in self antigens may initiate the au-
toimmune response has prompted the search for processes which induce novel fragmentation
of autoantigens as potential initiators of autoimmunity. The reversible ischemia reperfusion
which characterizes scleroderma has focused attention on reactive oxygen species as molecules
which might induce autoantigen fragmentation. We demonstrate that several of the autoanti-
gens targeted in diffuse scleroderma are uniquely susceptible to cleavage by reactive oxygen
species, in a metal-dependent manner. Multiple features of the fragmentation reaction and its
inhibition indicate that these autoantigens possess metal-binding sites, which focus metal-cata-
lyzed oxidation reactions (and consequent fragmentation) to specific regions of the antigens.
These data suggest that the autoantibody response in scleroderma is the immune marker of
unique protein fragmentation, induced by ischemia reperfusion in the presence of appropriate
metals, and focus attention on abnormal metal status as a potential pathogenic principle in this
disease.
 
T
 
he highly specific humoral immune response to auto-
antigens in many autoimmune diseases is antigen driven
and T cell dependent (1, 2), but the initial mechanisms for
breaking T cell tolerance to these molecules remain un-
clear. Several recent studies demonstrate that a potential for
T cell autoreactivity resides in the immunological non-
equivalency of different areas of self-molecules, since self-
tolerance is only induced to efficiently presented, dominant
epitopes, but not to cryptic ones (for reviews see references
3 and 4). Thus, potentially autoreactive T cells that have
not previously encountered the cryptic self still exist (5). As
determinant dominance is influenced by protein structure,
circumstances that change the molecular context of epi-
topes (e.g., novel cleavage, altered conformation, or tertiary
structure) may permit the efficient presentation of previ-
ously cryptic determinants, thereby breaking T cell toler-
ance (6–10). The unique autoantibody response observed
in different autoimmune diseases may therefore be viewed
as the long-lived immunologic memory of the altered cir-
cumstances that revealed this cryptic structure. Thus, these
antibodies are useful probes with which to search for the
initial perturbed state. For example, the autoantibodies
elaborated in systemic lupus erythematosus (SLE)
 
1
 
 have fo-
cused attention on apoptosis as a possible setting in which
cryptic structure is revealed. During apoptosis, the lupus
autoantigens cluster and become concentrated in the sur-
face blebs of apoptotic cells (11) where several of these
molecules are specifically cleaved by proteases of the inter-
leukin 1
 
b
 
 converting enzyme (ICE) family (12–14). The
fact that specific proteolytic cleavage unifies these lupus au-
toantigens has suggested that fragmentation might define
molecules as autoantigens in other autoimmune diseases (13).
Scleroderma is a disease of unknown etiology which is
characterized by increased vasoreactivity, widespread tissue
fibrosis, and the elaboration of unique autoantibodies. Since
the autoantigens recognized are not substrates for the ICE-like
enzymes during apoptosis, it is likely that other mechanisms
are responsible for revealing cryptic structure in this disease
(13). One potential mechanism that might result in the spe-
cific fragmentation of scleroderma autoantigens is suggested
by the striking reversible ischemia-reperfusion that occurs
in patients with scleroderma (for review see reference 15).
This vascular phenomenon, the result of dysfunction of
small arteries and arterioles of the extremities and internal
organs, has been proposed to underlie the exuberant tissue
fibrosis in this disease (16). The injury associated with re-
perfusion of ischemic tissues results in part from the pro-
duction of free radical species (17–19), and indirect evi-
dence exists for increased production of reactive oxygen
species (ROS) in patients with scleroderma (20, 21). Since
ROS can induce the oxidative modification of proteins
 
1
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(including fragmentation; 22 and 23), we used the autoanti-
bodies from scleroderma patients to address whether ROS-
mediated fragmentation might unify the autoantigens in
this disease.
 
Materials and Methods
 
Sera.
 
After obtaining informed consent, human autoimmune
sera were collected from 60 patients with diffuse scleroderma, and
their reactivity with saline soluble extracts of rabbit thymus was
determined by Ouchterlony immunodiffusion using standard ref-
erence serum to topoisomerase I. The sera were further screened
by immunoblotting against control HeLa cell lysates, using refer-
ence antibodies to NOR90/UBF, U1-70kDa, topoisomerase I,
and RNA polymerase I, II, and III as standards. Of the RNA
polymerases, only the large subunit of RNA polymerase II was
recognized by immunoblotting. Other autoimmune sera recog-
nizing lupus autoantigens have been described previously (11–13).
 
Metal-catalyzed Oxidation Reactions.
 
Confluent HeLa mono-
layers were washed twice with KRB (20 mM Hepes, pH 7.4,
127 mM NaCl, 5.5 mM KCl, 10 mM dextrose, 1 mM CaCl
 
2
 
,
and 2 mM MgSO
 
4
 
), and then lysed in a buffer containing 20 mM
Hepes, pH 7.4, 1% Nonidet P40, 150 mM NaCl, and the follow-
ing protease inhibitors: leupeptin, pepstatin A, chymostatin, anti-
pain, and PMSF. Equal lysate aliquots were pipetted into mi-
crofuge tubes before adding metal, H
 
2
 
O
 
2
 
, and/or ascorbate.
Samples were incubated at 25
 
8
 
C for 30 min, with vortexing every
5 min. Reactions were terminated by adding 10 mM EDTA,
SDS gel buffer, and boiling for 3 min. Equal protein amounts of
each sample were electrophoresed on 10% SDS-polyacrylamide
gels. Proteins were then transferred to nitrocellulose and immu-
noblotted with patient sera monospecific for topoisomerase I,
RNA polymerase II large subunit, UBF/NOR90, or U1-70kDa.
Blotted proteins were visualized using the Supersignal CL-HRP
substrate system (Pierce, Rockford, IL) according to the manu-
facturer’s directions. Primary antibodies were used at dilutions of
1:5,000–1:20,000, and autoradiogram exposure times ranged
from 2 s–1 min. Experiments were always performed using
freshly made lysate, and fresh stock solutions of Fe, Cu, H
 
2
 
O
 
2
 
,
and ascorbate. Oxygen depletion was accomplished by vigorously
blowing O
 
2
 
-free argon through the lysate for 5 min before adding
Fe and ascorbate. For these experiments, reactions on both con-
trol and O
 
2
 
-depleted lysates were performed in sealed tubes
(without vortexing) at 25
 
8
 
C for 30 min.
 
Metal Chelator, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide, and
Zinc Competition Experiments.
 
Metal-catalyzed oxidation reac-
tions were performed on HeLa lysates essentially as described
above, with the following modifications. Experiments performed
in the presence of 1 mM desferroxamine, 200 
 
m
 
M bathocuproine
disulfonate or 1 mM D-penicillamine were carried out by adding
the chelators immediately before addition of the Fe or Cu. ZnCl
 
2
 
competition reactions, and those performed in the presence of 5 mM
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDAC), were
executed by adding these reagents to HeLa lysates 5 min before
adding Fe/ascorbate.
 
Intact Cell Experiments.
 
Confluent monolayers (secondary pas-
sage) of human foreskin keratinocytes were cultured as described
(11). Experiments were initiated by adding keratinocyte growth
medium supplemented with 20 
 
m
 
M CuSO
 
4
 
 to the cells for 2 or
18 h. 2 mM H
 
2
 
O
 
2
 
 was subsequently added to some of the dishes,
and after a further 30 min incubation, the cells were harvested
and immunoblotted.
 
Morphologic Studies.
 
Microscopy was performed on HeLa cells
 
grown on No. 1 glass coverslips. For immunofluoresence, cells
were fixed in 4% paraformaldehyde (5 min, 4
 
8
 
C), permeabilized
in acetone (30 s, 4
 
8
 
C), and stained using a standard monospecific
patient serum recognizing topoisomerase I (diluted 1:160 in PBS).
Bound antibodies were visualized with FITC-conjugated goat
anti–human F(ab
 
9
 
)
 
2
 
 (Organon Teknika Corp./Cappel, Durham,
NC). Coverslips were mounted with Permafluor (Lipshaw, Pitts-
burgh, PA), and viewed on a scanning confocal microscope sys-
tem (MRC 600; Bio-Rad Laboratories, Richmond, CA). For
metal staining, cells were fixed in filtered 1% lead acetate, pH 5.5
(30 min, 37
 
8
 
C), washed extensively with H
 
2
 
O, and stained with
1% ammonium sulfide (5 min, 25
 
8
 
C). After extensive washing
with H
 
2
 
O, coverslips were mounted, viewed, and photographed
under bright field on a Zeiss Axiophot microscope.
 
Results
 
Scleroderma Autoantigens Are Fragmented by Metal-catalyzed
Oxidation Reactions.
 
Substantial evidence exists for the in
vitro production of reactive oxygen species (including hy-
droxyl radical [OH
 
•
 
]) via the metal-catalyzed Fenton (H
 
2
 
O
 
2
 
1
 
 Fe
 
2
 
1
 
(Cu
 
1
 
) 
 
®
 
 Fe
 
3
 
1
 
(Cu
 
2
 
1
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1
 
 OH
 
2
 
 
 
1
 
 OH
 
•
 
) and Haber-
Weiss reactions (O
 
2
 
2
 
•
 
 
 
1
 
 H
 
2
 
O
 
2
Fe/Cu
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O
 
2
 
 
 
1
 
 OH
 
2
 
 
 
1
 
 OH
 
•
 
)
(see reviews in references 24 and 25). In initial studies, we
added ferrous sulfate (Fe) to NP-40 lysates of HeLa cells to
generate free radical species by Fenton chemistry (26–29),
and addressed whether several of the major autoantigens in
diffuse scleroderma were fragmented (30–33). After incu-
bating in vitro for 30 min in the absence of added metal,
topoisomerase I remained stable, and migrated as a single
100-kD species (Fig. 1, lane 
 
1
 
). In these metal-free condi-
tions, addition of either ascorbate or H
 
2
 
O
 
2
 
 failed to gener-
ate any fragments (Fig. 1, lanes 
 
2
 
 and 
 
3
 
). Addition of 100 
 
m
 
M
Fe induced the specific fragmentation of topoisomerase I,
generating a major fragment of 95 kD, and several minor,
discrete species migrating between 65 and 90 kD (Fig. 1,
lane 
 
4
 
). In the presence of 1.7 mM ascorbate, generation of
these fragments was enhanced (Fig. 1, lane 
 
5
 
); the reaction
went to completion (that is, total loss of the intact protein)
when 17 mM ascorbate was added (data not shown). In
contrast, 1 mM H
 
2
 
O
 
2
 
 resulted in a slight, but reproducible,
decrease in fragmentation when compared to Fe alone (Fig. 1,
lane 
 
6
 
 versus lane 
 
4
 
). Fe also induced specific fragmentation
of three additional scleroderma autoantigens: the large sub-
unit of RNA polymerase II, upstream binding factor (UBF/
NOR90), and the 70 kD protein component of the U1
small nuclear ribonucleoprotein (U1-70kDa). Although the
sensitivity of the different proteins to metal-induced frag-
mentation varied (e.g., the large subunit of RNA poly-
merase II was efficiently fragmented using 
 
,
 
10 
 
m
 
M Fe),
cleavage was enhanced by the addition of ascorbate in all
cases: (
 
a
 
) the large subunit of RNA polymerase II (a protein
doublet of 220 and 240 kD) was specifically fragmented,
generating major species of 190, 160, and 140 kD, as well
as several minor species of 200, 180, 170, and 130 kD (Fig. 1,
lane 
 
5
 
); (
 
b
 
) Fragmentation of UBF/NOR90 (a doublet of
90 and 100 kD in control lysates) yielded a poorly resolved
smear of fragments between 70 and 90 kD (Fig. 1, lane 
 
5
 
),
(
 
c
 
) U1-70kDa fragmentation in response to Fe generated a 
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few discrete fragments that migrated between 33 and 38 kD
(Fig. 1, lane 
 
5
 
); this Fe-induced fragmentation was ineffi-
cient compared to that of the other autoantigens. Identical
U1-70kDa fragments were also observed when [
 
35
 
S]me-
thionine-labeled U1-70kDa was generated by coupled in
vitro transciption/translation, and then subjected to Fe/
ascorbate treatment (data not shown). In contrast to the au-
toantigens described above, fibrillarin, the major sclero-
derma ribonucleoprotein autoantigen, was not fragmented
under identical conditions (data not shown).
Some of the autoantigens that fragmented in response to
Fe/ascorbate were also fragmented in a Cu-catalyzed oxi-
dation system. Thus, specific fragments of topoisomerase I,
RNA polymerase II large subunit, and U1-70kDa were
observed when 100 
 
m
 
M Cu and 1 mM H
 
2
 
O
 
2
 
 were used to
initiate oxygen radical production (Fig. 1, lanes 
 
7–9
 
). In
contrast, no fragmentation of UBF/NOR-90 was detected
under these conditions (Fig. 1, lanes 
 
7–9
 
). Three striking
differences between the fragments generated by Cu/H
 
2
 
O
 
2
 
and those generated by Fe/ascorbate were noted. (
 
a
 
) Addi-
tion of Cu alone did not result in autoantigen fragmenta-
tion, which was dependent on the addition of H
 
2
 
O
 
2
 
. (
 
b
 
)
The fragments observed in response to Cu/H
 
2
 
O
 
2
 
 were dis-
tinct from those generated by Fe/ascorbate; Cu-induced
fragmentation of topoisomerase I produced a major species
of 95 kD, but did not generate the other fragments de-
tected in the Fe system (Fig. 1, lanes 
 
5
 
 and 
 
9
 
). Cu-induced
breakage of U1-70kDa generated a single product of 65 kD
(not seen in the Fe system), and did not give rise to the 33–
38kD fragments typical of Fe-induced fragmentation (Fig. 1,
lanes 
 
5
 
 and 
 
9
 
). Incubation with Cu/H
 
2
 
O
 
2
 
 induced aggre-
gation of the large subunit of RNA polymerase II (detected
as immunoreactive protein species migrating 
 
.
 
250 kD),
and also gave rise to several distinct cleavage fragments mi-
grating between 170 and 210 kD, which differed from the
predominant Fe-induced fragments (Fig 1, lanes 
 
5 and 9).
(c) Topoisomerase I, the large subunit of RNA polymerase
II, and UBF/NOR90 were more efficiently fragmented by
Fe/ascorbate than Cu/H2O2. In contrast, fragmentation of
U1-70kDa was more effectively induced with the latter
oxidation system.
Thus, several of the antigens frequently targeted in pa-
tients with diffuse scleroderma are specifically fragmented
in both of the metal-catalyzed oxidation systems we have
examined. The specificity of these fragmentation reactions
was confirmed in several different ways. (a) Except for the
decreased staining of a protein of z85 kD (Fig. 2 A, arrow),
the coomassie blue staining of cell lysates incubated with
Fe/ascorbate was not significantly different from control ly-
sates (Fig. 2 A, lanes 1 and 2). The coomassie blue staining
profile of control lysates, and those treated with Cu/H2O2
were identical (data not shown). These data are consistent
with previous observations showing that although modifi-
cation of proteins by metal-catalyzed reactions is frequent
(22, 23, 34), fragmentation of these proteins is an extremely
uncommon event (23). (b) Fragmentation reactions were
absolutely dependent on metals capable of supporting Fen-
ton chemistry (Fe, Cu); no autoantigen cleavages were
observed upon addition of 100 mM zinc, cobalt, mercury,
magnesium, manganese, nickel, cadmium, or silver, either
alone, in the presence of H2O2, or ascorbate (data not
shown). (c) None of the SLE autoantigens tested (including
52- and 60-kD Ro, La, and the Sm proteins), nor several
other proteins proteolytically cleaved during apoptosis (in-
cluding poly(ADP-ribose) polymerase, actin, and the nu-
clear mitotic apparatus protein, NuMA) were fragmented
in oxidation reactions containing Fe/ascorbate or Cu/
H2O2 (Fig. 2 B). (d) Identical fragments were produced in
.20 separate experiments, immunoblotted with 7 different
topoisomerase I sera, and 3 different RNA polymerase II
large subunits, U1-70kDa, and UBF/NOR90 sera (data
not shown). Identical fragments were also generated in ly-
sates of several different cell types, including human kerati-
nocytes and human umbilical vein endothelial cells (data not
shown). (e) Fragmentation was inhibited under O2-depleted
conditions (Fig. 2 C), confirming that the fragmentation was
free-radical mediated.
Figure 1. Several scleroderma autoantigens are uniquely fragmented by
Fe/ascorbate or Cu/H2O2 oxidation reactions. HeLa lysates were prepared as
described in the Materials and Methods section, and metal-catalyzed oxida-
tion reactions were performed by adding the following: no additions (lane 1),
1.7 mM ascorbate (lane 2), 1 mM H2O2 (lane 3), 100 mM Fe(II)SO4 (lane 4),
100 mM Fe(II)SO4 1 1.7 mM ascorbate (lane 5), 100 mM Fe(II)SO4 1 1
mM H2O2 (lane 6), 100 mM Cu(II)SO4 (lane 7), 100 mM Cu(II)SO4 1
1.7 mM ascorbate (lane 8) and 100mM Cu(II)SO4 1 1 mM H2O2 (lane
8). Samples were immunoblotted with the sera denoted on the left side of
each panel. Equal amounts of protein were electrophoresed in the lanes of
each panel. Migration positions of molecular weight standards are indi-
cated on the right.74 Metal-catalyzed Oxidation Cleaves Scleroderma Autoantigens
Metal Chelators, Zinc, or EDAC Inhibit the Fragmentation
of Scleroderma Autoantigens. The site-specific nature of metal-
catalyzed oxidation reactions has previously indicated that
these reactions are “caged” processes in which amino acid
residues at metal-binding sites are specific targets of highly
reactive free radical species generated at that site during a
Fenton reaction (25, 35, 36). Sequestration of metals by
chelators in the bulk solution, although only minimally in-
fluencing the capacity of the metal to catalyze a Fenton re-
action, prevents the metal from doing so at the metal-binding
site, thus inhibiting highly localized protein oxidation (25,
35). We therefore evaluated the effects of metal chelators
on the fragmentation reactions. Fe-induced cleavages were
markedly inhibited by 1 mM desferroxamine (Fig. 3 A,
lanes 2 and 4), 1 mM D-penicillamine (Fig. 3 A, lanes 2
and 8), or 1 mM EDTA (data not shown). Cu-induced
fragmentation was entirely abolished by 200 mM bathocu-
proine disulfonate (a Cu[I]-specific chelator; Fig. 3 A, lanes 3
and 7), and 1 mM EDTA (data not shown), and was dimin-
ished by 1 mM desferroxamine or 1 mM D-penicillamine
(Fig. 3 A, lanes 3, 5, and 9). These data strongly indicate
that metal binding to the autoantigen itself is required for
the fragmentation reactions to occur. Since fragmentation
requires exogenous metals capable of supporting a Fenton
reaction, we addressed whether zinc, a metal that poten-
tially binds to the same site, but is unable to support Fenton
chemistry, might influence the ability of Fe or Cu to in-
duce oxidative fragmentation. Increasing concentrations of
zinc were added to cell lysates before the addition of Fe/
ascorbate, and the effects on autoantigen fragmentation
were assessed (Fig. 3 B). Cleavage of topoisomerase I and
RNA polymerase II large subunit was inhibited by zinc in a
dose-dependent manner, with fragmentation entirely abol-
ished by 300 mM zinc (IC50 of 30–50 mM) (Fig. 3 B). A
similar IC50 for inhibition by zinc was observed for Cu/
H2O2-induced fragmentation of these autoantigens; in con-
trast, the specific aggregation of RNA polymerase II large
subunit induced by Cu/H2O2 was not prevented (data not
shown).
Interestingly, a striking structural feature common to
these fragmented autoantigens is extended charged tracts,
containing regions rich in acidic residues, or regions of
mixed charge (37). For example, topoisomerase I contains a
single highly charged (mixed) tract containing 72 residues,
NOR90/UBF contains two highly negatively charged tracts
of 21 and 28 residues, U1-70kDa contains two highly charged
(mixed) tracts containing 89 and 48 mixed residues, and the
large subunit of RNA polymerase II contains three highly
charged (mixed) tracts of 25, 17, and 12 residues. Since the
carboxylate side-chains of acidic residues constitute excel-
lent sites for metal chelation, we addressed whether chemi-
cal modification of the accessible carboxylates by 1-ethyl-
3-(3-dimethylaminopropyl)carbodiimide (EDAC) might alter
the metal-catalyzed fragmentation of these proteins. Ly-
sates of HeLa cells were incubated with 5 mM EDAC for
5 min before initiation of a metal-catalyzed oxidation reac-
tion by addition of Fe and ascorbate. EDAC significantly
decreased the specific cleavage of topoisomerase I (Fig. 3
C) and RNA polymerase II large subunit (data not shown),
indicating that negatively charged amino acid side chains
are involved in the fragmentation reaction. In contrast,
treatment with either diethyl pyrocarbonate (1 mM) or io-
doacetamide (1 mM) (which modify histidine and cysteine
residues, respectively), failed to decrease metal-catalyzed
Figure 2. Fragmentation of
scleroderma autoantigens by
oxidation is a highly specific
event. (A and B) Equal protein
amounts of control HeLa lysates
(lanes 1 and 3), and HeLa lysates
incubated with 100 mM Fe 1
1.7 mM ascorbate (lanes 2 and 4)
were electrophoresed. (A) Gels
were stained with Coomassie
blue to visualize the total protein
profile of each sample. Oxida-
tion catalyzed by Fe/ascorbate
caused no striking alterations in
the Coomassie pattern, with the
exception of the decreased
staining of an z85 kD protein
(arrow). Migration positions of the molecular weight standards are indi-
cated to the right of lane 2. (B) Electrophoresed proteins were immuno-
blotted with patient sera recognizing NuMA, La, and 52 and 60-kD Ro,
or a monoclonal antibody to fodrin (Chemicon International Inc., Te-
mecula, CA). None of these antigens were fragmented by Fe/ascorbate
oxidation reactions (lanes 3 and 4). (C) Fragmentation of RNA polymerase
II and topoisomerase I is decreased in O2-depleted lysates. O2 depletion
was performed as described in Materials and Methods, before adding 100
mM Fe and 1.7 mM ascorbate. Equal protein amounts were electro-
phoresed and immunoblotted with antibodies to RNA polymerase II and
topoisomerase I.75 Casciola-Rosen et al.
autoantigen fragmentation (data not shown). Taken to-
gether, the specific cleavage sites, inhibition by chelators
and EDAC, and competition by zinc strongly suggest that
the cleaved scleroderma autoantigens possess metal-binding
sites which focus metal-catalyzed oxidation and resulting
fragmentation at specific places. Since neither g-irradiation
(which generates OH• by radiolysis of H2O), nor addition
of H2O2 or ascorbate alone to control lysates results in au-
toantigen fragmentation (Fig. 1 and data not shown), it is
likely that the physiologic state of these sites is either unoc-
cupied, or occupied by a metal incapable of supporting
Fenton chemistry.
Specific Autoantigen Fragmentation Is Induced in Intact Cells
Chronically Exposed to Supraphysiologic Concentrations of Cop-
per. The absolute dependence of autoantigen fragmenta-
tion on exogenous Fe or Cu in cell lysates prompted us to
address whether similar autoantigen fragmentation could be
induced in intact cells chronically exposed to supraphysio-
logic concentrations of free Cu. Human foreskin kerati-
nocytes were cultured for 18 h in vitro in defined, serum-
and albumin-free growth medium supplemented with 20 mM
CuSO4. Oxidation reactions were initiated by adding 2 mM
H2O2 to some cultures for an additional 30 min. This
choice of cell type, metal ion and concentration, and H2O2
dose were based on preliminary studies which demon-
strated that (a) loading cells with Fe was not feasible, (b)
serum-free medium greatly facilitates the reproducible up-
take of Cu, and (c) 20 mM Cu (with H2O2) induces very
little fragmentation in the in vitro lysate system (data not
shown). Only intact topoisomerase I was detected in con-
trol keratinocytes (Fig. 4, lane 1), and H2O2 treatment
alone did not result in any autoantigen fragmentation (Fig. 4,
lane 2). Incubation with 20 mM Cu overnight did not af-
fect cell morphology or viability (data not shown), and did
not produce any fragmentation of topoisomerase I in the
absence of added H2O2 (Fig. 4, lane 3). In contrast, addi-
tion of H2O2 after overnight Cu loading resulted in the
marked fragmentation of topoisomerase I into the predom-
inant Cu-characteristic band of 95 kD (Fig. 4, lane 4). In-
cubation of cells in medium containing 20 mM Cu for 2 h
generated no topoisomerase I fragments in the presence or
absence of H2O2 (Fig. 4, lanes 5 and 6), clearly demonstrat-
ing that overnight preincubation of cells with Cu sensitizes
cells for H2O2-induced fragmentation of topoisomerase I.
Washing away the Cu-containing medium before adding
Figure 3. Metal chelators,
zinc, or EDAC strongly inhibit
or abolish fragmentation of the
scleroderma autoantigens in-
duced by both Fe/ascorbate and
Cu/H2O2. The following addi-
tions were made to equal protein
amounts of HeLa cell lysate, be-
fore immunoblotting with the
indicated antibodies: (A) none (lane 1), 100 mM Fe 1 1.7 mM ascorbate
(lanes 2, 4, 6, and 8); 100 mM Cu 1 1 mM H2O2 (lanes 3, 5, 7, and 9);
1 mM desferroxamine (lanes 4 and 5); 200 mM bathocuproine disul-
fonate (lanes 6 and 7), or 1 mM D-penicillamine (lanes 8 and 9). The
band migrating at 66 kD in the UBF/NOR90 immunoblot is nonspe-
cific. (B) Increasing concentrations of ZnCl2 (0–300 mM) were added to
HeLa lysates before addition of 100 mM Fe 1 1.7 mM ascorbate. The
IC50 value for inhibition of Fe/ascorbate-induced fragmentation of to-
poisomerase I or RNA polymerase II large subunit was 30–50 mM. (C)
HeLa lysates were incubated in the absence (2) or presence (1) of 5 mM
EDAC, before adding 100 mM Fe and 1.7 mM ascorbate. (A–C) Equal
protein amounts were loaded in each lane. Results are representative of
two to six separate experiments.
Figure 4. Topoisomerase I is fragmented in intact keratinocytes chron-
ically exposed to 20 mM Cu. Confluent monolayers of human foreskin ker-
atinocytes were cultured for 18 h (lanes 3 and 4) or 2 h (lanes 5 and 6) in
keratinocyte growth medium supplemented with 20 mM CuSO4. Con-
trol cultures were maintained in the absence of added Cu (lanes 1 and 2).
Before harvesting the cells, 2 mM H2O2 was added to some of the cul-
tures (lanes 2, 4, and 6), but not others (lanes 1 3, and 5), for 30 min.
Cells were subsequently harvested and immunoblotted with anti-topoi-
somerase I serum as described in Fig. 1. Equal amounts of protein were
electrophoresed in each lane. Results are representative of those obtained
in three separate experiments.76 Metal-catalyzed Oxidation Cleaves Scleroderma Autoantigens
H2O2 had little effect on the extent or characteristics of
fragmentation (data not shown), indicating that the Cu ef-
fect was cell associated. Since addition of 20 mM Cu and
H2O2 fails to induce autoantigen fragmentation in cell ly-
sates, the fragmentation observed in the intact cells pre-
incubated with this Cu concentration strongly implies that
higher localized concentrations of Cu are generated in
these cells, which facilitate binding of Cu to the relevant
autoantigens.
The most likely subcellular site in which these increased
metal concentrations occur is the nucleolus, since the scle-
roderma autoantigens are enriched in nucleoli (reviewed in
reference 33), and several histochemical studies have dem-
onstrated that the nucleolus has the unusual capacity to
concentrate metal ions, including silver, zinc, cobalt, and
lead (38–41). Morphologic studies were performed to eval-
uate whether the patterns of staining of scleroderma au-
toantigens and metals in the nucleolus were similar (Fig. 5).
Exclusive staining of punctate intranucleolar structures (nu-
cleolini) was observed when HeLa cells were fixed with
lead acetate and stained with ammonium sulfide (Fig. 5 A),
or when ethanol-fixed HeLa cells were incubated with a
solution containing zinc ions, before staining with di-
thizone (40, and data not shown). Identical punctate intra-
nucleolar structures were observed when confocal immuno-
fluoresence microscopy was performed with antibodies to
topoisomerase I (Fig. 5 B) and other scleroderma autoanti-
gens (data not shown).
Discussion
Although the mechanisms underlying the initiation and
propagation of scleroderma remain unclear, the constella-
tion of severe ischemia reperfusion (associated with tissue
injury), widespread fibrosis, and specific autoantibody re-
sponse are unique to this disease, and provide essential clues
to the initiating process. The great specificity of the au-
toantibody response for a limited number of molecules in
scleroderma strongly suggests that these molecules share
some feature, hitherto unrecognized, that renders them
susceptible to forces which reveal previously cryptic struc-
ture. The studies presented here demonstrate a striking fea-
ture that unifies several of the scleroderma autoantigens:
these molecules are cleaved at highly specific sites in a reac-
tion that requires metal binding and the generation of
ROS. Cleavage by this process is unique to this group of
autoantigens; numerous other proteins, including several
lupus autoantigens, are resistant to fragmentation by this
method. The sensitivity of the scleroderma antigens to
ROS-induced fragmentation focuses attention on episodic
ischemia reperfusion (a striking clinical feature of the dis-
ease) as the potential circumstance under which such frag-
mentation might occur in vivo, and provides a novel
framework within which to view the pathophysiology of
scleroderma.
Although several modifications of proteins (including
loss of catalytic activity [34], amino acid modification [22],
increase in proteolytic susceptibility [26], and increase in
acidity [22]) are commonly observed during metal-cata-
lyzed oxidation reactions, highly specific fragmentation of
protein molecules is an extremely unusual consequence
(23). Specific fragmentation can, however, be generated by
covalently linking redox-active coordination complexes
(e.g., ferrous EDTA or 1,10-phenanthroline-copper) to
specific sites on the protein, generating a highly selective
scission reagent at that site (36, 42, 43). The discrete au-
toantigen fragments described here, coupled with the inhi-
bition of fragmentation by chelators and the competition of
fragmentation by zinc, strongly indicate that these autoanti-
gens are unified by their capacity to assemble a highly fo-
cused scission reagent, likely by binding a redox active
metal at specific sites. The observation that the U1-70kDa
Figure 5. Metal ions and topoi-
somerase I are concentrated in punc-
tate intranucleolar structures. (A)
HeLa cells were fixed in 1% lead ac-
etate, and subsequently stained with
1% ammonium sulfide. Bright field
microscopy demonstrates intense
staining of punctate intranucleolar
structures (nucleolini). (B) HeLa
cells were stained with a monospe-
cific human serum recognizing to-
poisomerase I and FITC-goat anti–
human IgG, and were examined by
confocal fluoresence microscopy.
Diffuse nuclear staining, as well as
punctate intranucleolar structures
(nucleolini), are seen. Similar results
were obtained with six other mono-
specific topoisomerase I sera. Nucle-
olini were never stained when simi-
lar experiments were performed
using sera obtained from healthy in-
dividuals, or from Ro/La-positive
lupus patients. Bar, 10 mM.77 Casciola-Rosen et al.
fragments generated from protein translated in vitro are
identical to those observed in cell lysates further demon-
strates that specific fragmentation is a property of the pro-
tein itself, rather than merely its subcellular environment
(see below). Furthermore, there is direct evidence that an
aspartic acid-rich region in the large subunit of bacterial
RNA polymerase (which chelates the active center Mg21
ion; 44) can also bind Fe(II); under these circumstances,
fragmentation of the protein occurs in the region of the
metal-binding site in a reaction that requires generation of
hydroxyl radicals (44). Both metal binding and cleavage
were dependent upon the presence of an aspartic acid-rich
motif (DFDGD) (44), which is absolutely conserved in eu-
karyotic RNA polymerases I, II, and III (44). It is of great
interest that all three of the human RNA polymerases are
autoantigens in scleroderma (32); the sizes of the fragments
produced by metal-catalyzed oxidation of human RNA
polymerase II large subunit (Fig. 1) correspond well with
those predicted to arise if cleavage occured at the equiva-
lent DFDGD site in this molecule.
Interestingly, effective autoantigen fragmentation results
after prolonged incubation of intact cells with concentra-
tions of extracellular Cu that are unable to induce protein
fragmentation in cell lysates. The preincubation required
suggests several possibilities, including the development of
localized increases in the Cu concentration within the cell
over time, and/or the slow exchange of Cu for a metal al-
ready bound to the autoantigen. The observation that scle-
roderma autoantigens are enriched in nucleoli (reviewed in
reference 33; Fig. 5 B), where they colocalize with sites of
high-affinity metal binding (40, 45; and Fig. 5 A), is there-
fore of great interest. It suggests that these antigens are uni-
fied both by their capacity to bind metals and their location
at sites containing potentially increased local concentrations
of redox active metals (see below).
The importance of autoantigen fragments as potential
initiators of the autoimmune process has been underscored
(3, 4). A recent study demonstrating the existence of au-
toreactive T cells which recognize several fragments of to-
poisomerase I (46) indicates that this proposed mechanism
is feasible in scleroderma. Clearly, it will be critical to de-
termine whether the novel scleroderma autoantigen frag-
ments that we have demonstrated in this study are indeed
able to break tolerance to the intact self molecules. The ob-
servation that fibrillarin, a major ribonucleoprotein autoan-
tigen in scleroderma, is not cleaved by metal-catalyzed oxi-
dation reactions is reminiscent of several ribonucleoprotein
autoantigens targeted in SLE, which are not cleaved by
ICE-like proteases during apoptosis (13). Since metal-cata-
lyzed oxidation may also have effects on the structure of
the nucleic acid components of these complex autoanti-
gens, it is possible that other mechanisms might be respon-
sible for revealing previously cryptic epitopes in these cir-
cumstances. It is also possible that exotic metal binding may
alter the structure of these complexes. In this regard, it is of
interest that a specific autoantibody response to fibrillarin is
observed in metal-overloaded mice (47, 48).
We propose that the autoantibody response in sclero-
derma is the immune marker of unique protein structure,
induced and driven by cycles of ischemia reperfusion. Since
unique protein fragmentation is only observed when Fe or
Cu is present, and can be induced in intact cells chronically
exposed to supraphysiologic concentrations of Cu, we fur-
ther suggest that abnormal cellular metal accumulation
might be of critical pathogenic importance in scleroderma.
In this regard, it is of great interest that D-penicillamine, a
metal chelator that prevents autoantigen fragmentation in
vitro, appears to improve the outcome in patients with dif-
fuse scleroderma, when used for extended periods (49, 50).
The observation that zinc decreases the fragmentation of
these autoantigens is intriguing, and may have therapeutic
implications. Whether a metal abnormality might also have
some influence on vascular reactivity, lowering the thresh-
old for developing vasospasm, and initiating a cycle of
damage, remains to be determined. The characteristic au-
toantigen footprints produced by metal-catalyzed oxidation
reactions will be important tools with which to study the
existence, sites, mechanisms, and significance of autoanti-
gen fragmentation in perturbed tissues of patients with scle-
roderma.
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